Immune regulation and CNS autoimmune disease

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 181-189

  Antel, Jack P ^a   Owens, Trevor ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GLATIRAMER; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; METALLOPROTEINASE; MYELIN PROTEIN; NEUROTROPHIN; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CYTOKINE RELEASE; GLIA CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033399126     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00186-1     Document Type: Article

References (96)

1. Aharoni R., Teitelbaum D., Sela M., Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J. Neuroimmunol. 91:1998;135-146.
2. Aloisi F., Penna G., Polazzi E., Minghetti L., Adorini L. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J. Immunol. 162:1999;1384-1391.
3. Antel J.P., Owens T. The attraction of adhesion molecules. Ann. Neurol. 34:1993;123-124. editorial.
4. Antel J., Qin Y., Zhang D., Crowe P., Conlon P. Vaccination with an altered MBP-peptide induces a persistent immune response. Neurology. 52:1999;A264-A264.
5. Ausubel L.J., Krieger J.I., Hafler D.A. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99. J. Immunol. 159:1997;2502-2512.
6. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
7. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6873-6878.
8. Bauer J., Huitinga I., Zhao W., Lassmann H., Hickey W.F., Dijkstra C.D. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia. 15:1995;437-446.
9. Bauer J., Bradl M., Hickey W.F., Forss-Petter S., Breitschopf H., Linington C., Wekerle H., Lassmann H. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition [see comments]. Am. J. Pathol. 153:1998;715-724.
10. Becher B., Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia. 18:1996;1-10.
11. Becher, B., Blain, M., Antel, J. CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J. Neuroimmunol., in press.
12. Becher B., Dodelet V., Fedorowicz V., Antel J.P. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1996;1539-1543.
13. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:1998;3299-3306.
14. Blain M., Nalbantoglu J., Antel J. Interferon-gamma mRNA expression in immediately ex-vivo CSF T cells. J. Neuroimmunol. 54:1994;149.
15. Bonetti B., Pohl J., Gao Y.L., Raine C.S. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159:1997;5733-5741.
16. Bourdoulous S., Beraud E., Le Page C., Zamora A., Ferry A., Bernard D., Strosberg A.D., Couraud P.O. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1. Eur. J. Immunol. 25:1995;1176-1183.
17. Brosnan C.F., Bornstein M.B., Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:1981;614-620.
18. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
19. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
20. Calabresi P.A., Tranquill L.R., Dambrosia J.M., Stone L.A., Maloni H., Bash C.N., Frank J.A., McFarland H.F. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b. Ann. Neurol. 41:1997;669-674.
21. Calabresi, P., Prat, A., Rollins, J., Antel, J., 1999. T-cells treated with interferon beta induce VCAM expression on brain endothelial cells: Concomitant shedding of soluble VCAM mirrors in vivo effect. ECTRIMS 99, in press.
22. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 161:1998;3365-3374.
23. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1999;1005-1010.
24. David S., Bouchard C., Tsatas O., Giftochristos N. Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron. 5:1990;463-469.
25. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
26. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 307:1984;273-276.
27. Ford A.L., Foulcher E., Lemckert F.A., Sedgwick J.D. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1996;1737-1745.
28. Gaur A., Boehme S.A., Chalmers D., Crowe P.D., Pahuja A., Ling N., Brocke S., Steinman L., Conlon P.J. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J. Neuroimmunol. 74:1997;149-158.
29. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:1999;170-175.
30. Gregersen, R., Lambertsen, K., Finsen, B., 1999. Microglia/macrophages are the major source of tumour necrosis factor in permanent middle cerebral artery occlusion (pMCAO) in mice. J. Cereb. Blood Flow Metab., in press.
31. Hardin-Pouzet H., Krakowski M., Bourbonniere L., Didier-Bazes M., Tran E., Owens T. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia. 20:1997;79-85.
32. Hart M.N., Fabry Z. CNS antigen presentation. Trends Neurosci. 18:1995;475-481.
33. Hemmer B., Vergelli M., Calabresi P., Huang T., McFarland H.F., Martin R. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99). J. Neurosci. Res. 45:1996;852-862.
34. Hermans G., Stinissen P., Hauben L., Berg-Loonen E., Raus J., Zhang J. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann. Neurol. 42:1997;18-27.
35. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:1991;254-260.
36. Huitinga I., van Rooijen N., De Groot C.J., Uitdehaag B.M., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1990;1025-1033.
37. Jensen M.A., Arnason B.G., Toscas A., Noronha A. Preferential increase of IL-2R+ CD4+ T cells and CD45RB-CD4+ T cells in the central nervous system in esperimental allergic encephalomyelitis. J. Neuroimmunol. 38:1992;255-261.
38. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
39. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189:1999;865-870.
40. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1364.
41. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
42. Krakowski M.L., Owens T. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2840-2847.
43. Kuchroo V.K., Greer J.M., Kaul D., Ishioka G., Franco A., Sette A., Sobel R.A., Lees M.B. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:1994;3326-3336.
44. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:1997;307-312.
45. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
46. Lucchinetti C.F., Bruck W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6:1996;259-274.
47. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. Beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18:1998;4451-4460.
48. Menendez I.B., Cerase J., Ceracchini C., Levi G., Aloisi F. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J. Neuroimmunol. 72:1997;83-93.
49. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:1999;49-55.
50. Nagelkerken L., Blauw B., Tielemans M. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 9:1997;1243-1251.
51. Nawashiro H., Tasaki K., Ruetzler C.A., Hallenbeck J.M. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17:1997;483-490.
52. Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfl J.F., Gardinier M., Barrett T.A., Miller S.D. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:1997;614-621.
53. Noble P.G., Antel J.P., Yong V.W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res. 633:1994;83-90.
54. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
55. Oh L.Y., Yong V.W. Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix. Glia. 17:1996;237-253.
56. Owens T., Renno T., Taupin V., Krakowski M. Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunol. Today. 15:1994;566-571.
57. Owens T., Tran E., Hassan-Zahraee M., Krakowski M. Immune cell entry to the CNS - a focus for immunoregulation of EAE. Res. Immunol. 149:1998;781-789.
58. Perry V.H., Andersson P.B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-273.
59. Pette M., Pette D.F., Muraro P.A., Farnon E., Martin R., McFarland H.F. Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes. Neurology. 49:1997;385-392.
60. Popko B., Corbin J.G., Baerwald K.D., Dupree J., Garcia A.M. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14:1997;19-35.
61. Prat A., Becher B., Blain M., Antel J. Induction of B7.1 and B7.2 Co-stimulatory molecule on the surface of human brain endothelial cells. J. Neuroimmunol. 90:1998;24-24.
62. Prat A., Al Asmi A., Duquette P., Antel J.P. Lymphocyte migration and multiple sclerosis: relation with disease course and therapy. Ann. Neurol. 46:1999;253-256. In Process Citation.
63. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
64. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., Kreutzberg G.W. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J. Neurosci. 18:1998;5804-5816.
65. Ransohoff R.M. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J. Leukocyte Biol. 62:1997;645-652.
66. Renno T., Zeine R., Girard J.M., Gillani S., Dodelet V., Owens T. Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int. Immunol. 6:1994;347-354.
67. Renno T., Lin J.Y., Piccirillo C., Antel J., Owens T. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49:1994;1-7.
68. Renno T., Krakowski M., Piccirillo C., Lin J.Y., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154:1995;944-953.
69. Renno T., Taupin V., Bourbonniere L., Verge G., Tran E., De Simone R., Krakowski M., Rodriguez M., Peterson A., Owens T. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell Neurosci. 12:1998;376-389.
70. Rivers T., Sprunt D., Berry G. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58:1933;39-53.
71. Rott O., Tontsch U., Fleischer B. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens. J. Immunol. 150:1993;87-95.
72. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today. 19:1998;568-574.
73. Schmied M., Breitschopf H., Gold R., Zischler H., Rothe G., Wekerle H., Lassmann H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:1993;446-452.
74. Sedgwick J.D., Schwender S., Imrich H., Dorries R., Butcher G.W., ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7438-7442.
75. Sedgwick J.D., Schwender S., Gregersen R., Dorries R., ter Meulen V. Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J. Exp. Med. 177:1993;1145-1152.
76. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
77. Stalder A.K., Carson M.J., Pagenstecher A., Asensio V.C., Kincaid C., Benedict M., Powell H.C., Masliah E., Campbell I.L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 153:1998;767-783.
78. Stark, S., Alexandria, V., Lindsey, J., Oger, J., Lublin, F., Antel, J., Sanielevici, M., Bourgouin, P., Evans, A., Crowe, P., Murphy, D., 1999. Double-blind, randomized, placebo-control, parallel-group evaluation of the safety and effect on immunologic parameters of the altered peptide ligand MSP771 in patients with MS. ECTRIMS, in press.
79. Steinman L. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy. J. Exp. Med. 189:1999;1021-1024.
80. Taupin V., Renno T., Bourbonniere L., Peterson A.C., Rodriguez M., Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur. J. Immunol. 27:1997;905-913.
81. Tran E.H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
82. Tran E.H., Hoekstra K., van Rooijen N., Dijkstra C.D., Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161:1998;3767-3775.
83. Tuohy V.K., Yu M., Yin L., Kawczak J.A., Kinkel R.P. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189:1999;1033-1042.
84. Vowinckel E., Reutens D., Becher B., Verge G., Evans A., Owens T., Antel J.P. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 50:1997;345-353.
85. Weinberg A.D., Wyrick G., Celnik B., Vainiene M., Bakke A., Offner H., Vandenbark A.A. Lymphokine mRNA expression in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis is associated with a host recruited CD45R hi/CD4+ population during recovery. J. Neuroimmunol. 48:1993;105-117.
86. Weiner H.L. Oral tolerance with copolymer 1 for the treatment of multiple sclerosis. Proc. Nat. Acad. Sci. U.S.A. 96:1999;3333-3335.
87. Wekerle H. The viral triggering of autoimmune disease. Nat. Med. 4:1998;770-771.
88. Wekerle H., Linington C., Lassmann H., Meyermann Cellular immune reactivity with the CNS. Trends Neurosci. 9:1986;271-277.
89. White C.A., McCombe P.A., Pender M.P. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82:1998;47-55.
90. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
91. Williams K., Ulvestad E., Cragg L., Blain M., Antel J.P. Induction of primary T cell responses by human glial cells. J. Neurosci. Res. 36:1993;382-390.
92. Williams K.C., Dooley N.P., Ulvestad E., Waage A., Blain M., Yong V.W., Antel J.P. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J. Neurosci. 15:1995;1869-1878.
93. Windhagen A., Anderson D.E., Carrizosa A., Balashov K., Weiner H.L., Hafler D.A. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis. J. Neuroimmunol. 91:1998;1-9.
94. Wraith D.C., Smilek D.E., Mitchell D.J., Steinman L., McDevitt H.O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:1989;247-255.
95. Xiao B.G., Bai X.F., Zhang G.X., Link H. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats. J. Neuroimmunol. 84:1998;230-237.
96. Zeine R., Owens T. Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RB(low) CD4+ T cells that induce experimental allergic encephalomyelitis. J. Neuroimmunol. 40:1992;57-69.